Zhang Lijun, Dai Lei, Li Deyuan
Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China.
Key Laboratory of Birth Defects and Related Disease of Women and Children (Sichuan University), Ministry of Education, Chengdu, China.
Front Pediatr. 2022 Oct 21;10:1031432. doi: 10.3389/fped.2022.1031432. eCollection 2022.
Hemophagocytic lymphocytosis (HLH) is a rare life-threatening hyperinflammatory syndrome in which early mortality remains high in patients with HLH.
We retrospectively collected the medical records of all pediatric patients diagnosed with HLH at the West China Second Hospital of Sichuan University between January 2014 and December 2020. Collect demographic, laboratory, clinical, genetic profiles, treatment information and perform statistical analysis from records. Risk factors for death 30 days after admission were evaluated using a multivariable logistic regression model.
A total of 110 pediatric HLH patients were enrolled. The median age of patients was 44 months (IQR 23-100.5) and 62 (56.4%) in males. The 30-day mortality rate for admission to this cohort was 34 (30.9%). Multivariate logistic regression analysis showed that heart failure (OR = 13.389, 95% CI, 1.671-107.256, = 0.015) and hypoproteinemia (OR = 4.841, 95% CI, 1.282-18.288, = 0.020) were associated with increased early mortality in children with HLH.
These identified risk factors may help clinicians stratify patients with HLH and develop targeted treatment strategies. More research is needed to explore the best treatment strategies for patients with HLH to reduce early mortality in patients with HLH.
噬血细胞性淋巴细胞增多症(HLH)是一种罕见的危及生命的高炎症综合征,HLH患者的早期死亡率仍然很高。
我们回顾性收集了2014年1月至2020年12月在四川大学华西第二医院诊断为HLH的所有儿科患者的病历。从记录中收集人口统计学、实验室、临床、基因特征、治疗信息并进行统计分析。使用多变量逻辑回归模型评估入院30天后的死亡风险因素。
共纳入110例儿科HLH患者。患者的中位年龄为44个月(IQR 23 - 100.5),男性62例(56.4%)。该队列入院的30天死亡率为34例(30.9%)。多变量逻辑回归分析显示,心力衰竭(OR = 13.389,95% CI,1.671 - 107.256,P = 0.015)和低蛋白血症(OR = 4.841,95% CI,1.282 - 18.288,P = 0.020)与HLH患儿早期死亡率增加相关。
这些确定的风险因素可能有助于临床医生对HLH患者进行分层,并制定有针对性的治疗策略。需要更多的研究来探索HLH患者的最佳治疗策略,以降低HLH患者的早期死亡率。